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Summary
Objectives: The aim of this study was to describe the clinical characteristics of childhood
intussusception and to estimate the incidence rate of intussusception before the introduction
of rotavirus vaccines in Korea.
Methods: Demographic, clinical, diagnostic, treatment, and outcome data for patients aged <5
years who were diagnosed with intussusception in Jeonbuk Province, South Korea from January
2000 through December 2002, were retrospectively collected using a standardized data collection
instrument.
Results: During the 3-year period, 408 patients were diagnosed with intussusception; 82.8% of
children were aged<24 months. Predominant signs and symptoms were vomiting (64.5%), bloody
stool (43.9%), and abdominal pain/irritability (41.9%). The combination of ultrasound and barium
or air enema was the most frequently used diagnostic approach (38.7%). Three hundred and
thirteen patients (76.7%) were treated by radiologic reduction, 88 (21.6%) patients were treated
by surgical intervention, and the remaining seven patients had no treatment. The mean annual
incidence rate of intussusception in Jeonbuk Province was 236/100 000 among children aged <2
years and 106/100 000 among children aged <5 years.
§ Results reported in this manuscript were presented in part at the 11th Asian Congress of Pediatrics, November 11—12, 2003, Bangkok,
Thailand.
* Corresponding author. Tel.: +82 2 872 2801; fax: +82 2 872 2803.
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Conclusions: This retrospective study provides a background incidence rate of childhood intussus-
ception in Korean children before the introduction of the rotavirus vaccine.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Intussusception (IS) is an acute obstructive process that
occurs in segments of the small intestine in infants and young
children.1 In 1999, IS gained increased recognition when
cases were observed in infants after receipt of the first
and second doses of an oral, live attenuated rotavirus vaccine
after the vaccine was introduced in the USA.2 AWorld Health
Organization (WHO) meeting on IS and rotavirus vaccination
highlighted the need for additional studies to describe the
epidemiology of IS.3 Recent studies in South Korea have
confirmed the importance of rotavirus diarrhea as a leading
cause of morbidity among children aged <5 years. Rotavirus
disease burden studies in South Korea suggest that there are
56.9 cases/1000 children aged <5 years each year and high-
light the potential value of new generation rotavirus vac-
cines.4 Given the previous experience with rotavirus vaccine
and IS, we performed a population-based assessment of IS
prior to licensure and introduction of rotavirus vaccines in
South Korea. This study was designed to describe the clinical
characteristics of childhood IS and to estimate the incidence
rate of IS in a defined population of children aged<5 years in
South Korea.
Methods
Study area and hospitals
This study was approved by the institutional review board of
the International Vaccine Institute and local scientific review
committees in Jeonbuk Province, South Korea. In Jeonbuk
(2001 population: 127 687 children <5 years old5), children
with IS would have been cared for at any of eight medical
facilities (two university hospitals, four secondary medical
centers, and two local radiologic clinics) during the study
period. It would have been very unusual for childrenwith IS to
be cared for in hospitals outside of the province.
Patient selection
Children were deemed eligible for this study if they were
diagnosed during the 3-year study period (January 2000
through December 2002) and aged <5 years at the time
of diagnosis and treatment. Children with a hospital dis-
charge diagnosis of IS were identified from computerized
hospital discharge databases in each participating hospital.
We used the International Classification of Diseases (ICD)
diagnostic codes for IS (ICD-9-CM (560.0) and ICD-10-CM
(56.1)) to identify children with IS at discharge. Medical
charts for children with IS were located in the hospital
medical records departments. Patient logbooks in the
departments of emergency medicine, radiology, and sur-
gery were reviewed to identify additional patients who may
have been missed in the selection of records from the
hospital discharge database.Data collection and database management
Standardized, pilot-tested data collection instruments
were created to abstract information from hospital or
clinic medical charts to collect demographic, clinical,
diagnostic, treatment, and outcome-related information.
English language data forms were used for abstraction and
these data were later entered onto an English language
data form for computer data entry. Study personnel under-
went training to ensure standardized data collection and
computer data entry prior to the start of the study. Data
were entered into computerized databases prior to running
standard checks for range and consistency errors as well as
missing data.
Data analysis
Patients with IS in Korea were analyzed by year of hospita-
lization, age group, and sex plus clinical, diagnostic, and
treatment characteristics. The age distributions of children
with IS in Korea were studied using the Chi-square test for
linearity. Standard Chi-square test statistics were computed
to compare categorical variables and the Fisher’s exact test
(two-tailed) was used when cell sizes were <5. Statistical
significance was indicated by a two-tailed p-value of <0.05.
Ninety-five percent confidence intervals (95% CI) were cal-
culated using the Wilson score method.6
Results
Age and seasonal distribution
A total of 408 children aged<5 years were identified from the
medical records as diagnosed and treated for IS from January
2000 through December 2002 in Jeonbuk Province. Among the
408 children, 18.9% of patients were aged <6 months and
82.8% were aged <24 months (Figure 1). In addition, among
the 214 infants aged <11 months, there were two infants
aged 1—5 weeks, 12 infants aged 6—14 weeks, 53 infants aged
15—24 weeks, 45 infants aged 25—32 weeks, and 102 infants
aged 33—52 weeks. Over the 3-year study period, the dis-
tribution of IS suggests a slight predominance of cases in the
late spring and early summer months (May through August)
(Figure 2).
Clinical patterns and diagnosis of IS
The mean number of days from onset of symptoms to medical
attention was less than one day (mean 0.69 days, range 0—5
days). The most common clinical signs and symptoms of IS
were vomiting (64.5%), bloody stool (43.9%), and abdominal
pain/irritability (41.9%) (Table 1). The most commonly used
diagnostic method was a combination of barium enema and
ultrasound (29.4%), followed by ultrasound only (24.3%)
(Table 2).
Figure 1 Age distribution of intussusception in children aged <5 years, Jeonbuk Province, South Korea, January 2000—December
2002.
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Three hundred and thirteen children with IS (76.7%) were
successfully treated by radiologic reduction and 88 cases
(21.6%) underwent surgical treatment. Seven children diag-
nosed with IS had spontaneous reduction of their IS during the
radiographic diagnostic procedure (Table 3). Overall, 12
children were transferred to other hospitals for further care
and one death was identified during this study period.
Figure 2 Monthly distribution of intussusception in children age
2002.Incidence and burden of intussusception
The male to female ratio was 1.5:1. Based on infant and
childhood age group populations in Jeonbuk Province, we
estimated the overall incidence of IS as well as rates for
infants and older children (Table 4). The average annual
incidence of IS among children aged <5 years during this
3-year period was 106/100 000 in Jeonbuk Province. The
average annual incidence of IS among children aged<2 years
Table 1 Clinical signs and symptoms of children aged <5
years with intussusception, Jeonbuk Province, South Korea,
January 2000—December 2002
Sign/symptom Cases (N = 408)
n %
Vomiting 263 64.5
Red currant jelly stools 179 43.9
Abdominal pain/irritability 171 41.9
Diarrhea 68 16.7
Abdominal mass 54 13.2
Classic triada 31 7.6
Fever 29 7.1
a Triad includes abdominal pain, red currant jelly stools, and
vomiting.
Table 3 Treatment method for intussusception cases aged
<5 years, Jeonbuk Province, South Korea, January 2000—
December 2002 (N = 408)
Treatment method n %
Radiologic reduction 313 76.7
Surgery 88 21.6
No treatment 7 1.7
Total 408 100
Table 4 Incidence of intussusception-associated hospitali-
zations in children aged <5 years, Jeonbuk Province, South
Korea, January 2000—December 2002 (N = 408)
Characteristic n (%) Ratea (95% confidence
e386 D.S. Jo et al.during this 3 year-period in Korea was 236/100 000. Using
national population census data for the age group of children
<5 years and the mean annual incidence rate among children
aged <5 years, we would expect 3318 IS cases per year in
Korean children aged <5 years.
Discussion
IS among the children of Korea is a well-recognized clinical
entity that is most common among children aged <24
months. There was no significant seasonal variation except
for a slight predominance of cases in the late spring and early
summer months, and it appeared unrelated to seasonal
variations in the incidence of rotavirus gastroenteritis in
Korea. Similarly, previous studies on the epidemiology of IS
in other countries have shown neither a significant seasonal
pattern nor a correlation with rotaviral infections.7—11
In this study, children with IS presented mainly with
vomiting, bloody stool, and/or abdominal pain/irritability,
in order of frequency. This presentation differs from thatTable 2 Diagnostic method for intussusception cases aged
<5 years, Jeonbuk Province, South Korea, January 2000—
December 2002 (N = 408)
Diagnostic method n %
Barium enema and ultrasonography 120 29.4
Ultrasonography 99 24.3
Air enema 58 14.2
Barium enema, ultrasonography,
and other procedures
41 10.0
Air enema and ultrasonography 38 9.3
Barium enema 20 4.9
Barium enema and other procedures 20 4.9
Air enema, ultrasonography, and surgery 3 0.7
Ultrasonography and surgery 2 0.5
Ultrasonography and other procedures 2 0.5
Air enema and surgery 1 0.2
Other procedures 1 0.2
Surgery 1 0.2
Unknown 2 0.5
Total 408 100found in other studies. For example, in a study on IS-asso-
ciated hospitalization of Venezuelan infants, 83% of the cases
had bloody stools, 81% had vomiting, and 44% had severe
colicky pain.10 In contrast, in Australia, crying/irritability/
abdominal pain was reported in all patients, vomiting in 91%,
and bloody stool in 59%.8 In addition, our study showed that
the proportion of cases presenting fully with this classic triad
was only 8%. This is much lower than that of the Australian
study (43%). These observations highlight the significant
country-to-country variation in presenting symptoms of IS,
and should alert clinicians to the importance of awareness of
the local clinical symptoms and signs.
For the diagnosis of IS, clinicians in Korea detected 50.5%
of cases with a combination of modalities (ultrasound fol-
lowed by confirmatory air/barium enema with or without
other procedures). The overall rate of diagnostic use of
ultrasonography was 74.8% in our study, comparable with
the rates of other countries.12—15 In part, the variations in
diagnostic methods found in this study may reflect differ-
ences in the health systems and levels of capital investment
in diagnostic equipment for hospitals in Korea.interval)
Age group (months)
<6 77 (18.9) 236.2 (160.9, 346.8)
6—11 137 (33.6) 420.3 (314.9, 560.7)
12—23 124 (30.4) 158.7 (117.1, 214.9)
24—35 43 (10.5) 56.5 (33.9, 94.3)
36—47 15 (3.7) 18.6 (7.9, 43.5)
48—60 12 (2.9) 14.4 (5.6, 37.1)
Sex
Boys 246 (60.3) 123.6 (99.6, 153.4)
Girls 162 (39.7) 87.8 (67.3, 114.6)
Year
2000 156 (38.2) 125.8 (107.6, 147.2)
2001 152 (37.3) 119.0 (101.6, 139.5)
2002 100 (24.5) 87.4 (71.9, 106.3)
Total 408 (100) 106.4 (90.0, 125.9)b
a Age group-specific incidence rates are expressed as cases/
100 000 children. Rates for gender and admission year are
expressed as cases/100 000 <5 years of age.
b Mean annual incidence rate among children aged <5 years for
the 3-year study period.
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important implications for prospective IS surveillance. A grow-
ing body of literature has suggested that ultrasonography may
provide sufficient diagnostic accuracy to rule out the presence
of IS and guide appropriate therapy.16,17 In addition, ultra-
sound-guided hydrostatic reduction of IS can be an effective
alternative to more invasive diagnostic and treatment
modes.1,18 Data from the present study also suggest that
ultrasound alone may yield results similar to the use of a
combination of modalities. Seven patients in this study had
spontaneous reduction of IS during the radiographic diagnostic
procedure, saving the patients from an extended post-surgical
recuperation period. Ideally, prospective IS surveillancewould
provide a unique opportunity to evaluate the sensitivity and
specificity of different diagnostic modalities, as well as allow-
ing determination of the most cost-effective approach to IS
diagnosis. Currently there are few data on the cost-effective-
ness of different approaches to IS diagnosis, but there is some
suggestion that treatment with non-invasive means may
reduce overall patient morbidity, reduce hospital length of
stay, and lead to cost savings for the healthcare system.
The mean annual IS incidence data of this study are
comparable to those from other counties. Our results suggest
that the overall IS rate among Korean infants aged <5 years
was slightly higher than those reported previously in Hong
Kong (78—100/100 000)11 and Japan (78/100 000).7
In our study, 82.8% of children with IS were aged <24
months, consistent with previous case series findings in Asia
and elsewhere that have shown most IS occurring in infants
and toddlers.7,10,19 The peak incidence occurred at 6—11
months, consistent with developed countries and earlier
records, but dissimilar from developing countries such as
Thailand where the peak incidence was found to occur at
<6 months of age.27 Furthermore, in Korea, 52.5% of IS
patients were 0—11 months of age–—a proportion similar to
that found by Nelson and colleagues in Hong Kong (52%)11 and
that found by Nakagomi and colleagues in Japan (55%).7 Of
note, 18.9% of patients in Korea were <6 months old.
The incidence rate in Korean infants aged <1 year was
similar to those found in non-white/non-black infants
(includes Asian-Pacific Islanders and other racial groups) in
California and Indiana (112/100 000 and 217/100 000,
respectively), yet higher than rates found in whites (35/
100 000 (California) and 27/100 000 (Indiana)) or blacks
(32/100 000 (California) and 50/100 000 (Indiana)).20 The
incidence rate in infants aged <1 year was 185/100 000 in
Japan7 and 302 per 100 000 in Vietnam.21 In contrast, Webby
and colleagues reported that the incidence rate of IS was
lower in Aboriginal and Torres Strait Islander children (0.16/
1000 live birth) than non-Aboriginal and Torres Strait Islan-
ders in the Northern Territory of Australia (0.92/1000 live
birth).15 It is still unclear what role the genetic and the
spectrum of associated pathogens and other environmental
factors may play in explaining the differences in IS rates
observed in different areas and different races.
A number of studies have considered the timing of rota-
virus vaccination with respect to the occurrence of IS among
infants in the USA and other countries. Following the intro-
duction of RotaShield1 in the USA, Simonsen et al. reported
that the incidence of intussusception associated with the first
dose increased with age, especially after 90 days of age.22,23
In a recent study by Tate et al., hospitalization rates for ISwere very low for young infants (<9 weeks of age).24 In
addition, older infants aged 26—29 weeks experienced the
highest rates of IS (peak incidence of approximately 62/
100 000). Interestingly, the distribution of IS among infants
in our study was similar to the distribution of IS cases
reported by Tate et al. (22% of infant IS cases occurring
among those aged 25—32 weeks and 46% of infant IS cases
occurring among infants aged 33—52 weeks).
Recently, the results of post-licensure monitoring for IS in
the USA during the first 18 months following introduction of
the pentavalent rotavirus vaccine were released.25 In this
analysis, administration of the pentavalent rotavirus vaccine
was not associated with an increase in the incidence of IS,
particularly within 21 days following rotavirus vaccination. In
Korea, both the pentavalent and the monovalent rotavirus
vaccines have been licensed for administration to infants
(June 2007 and March 2008, respectively). While uptake of
rotavirus vaccines in Korea is still lower (approximately 30%)
than in the USA, continued surveillance for IS in Korean
infants will be needed to detect changes in the IS incidence
among infants and children.26
Our study has some limitations. First, diagnosis of IS was
not standardized in the field sites and thus some patients may
have been misclassified. Also, definitions of signs and symp-
toms may vary somewhat based on local clinical interpreta-
tion as well as clinician training and experience. Knowledge
of these important cultural and healthcare access differ-
ences must be incorporated into carefully designed prospec-
tive IS surveillance in areas where rotavirus vaccines may be
evaluated or introduced.
Current rotavirus disease burden estimates in Korea sug-
gest that rotavirus is a major cause of both outpatient clinic
visits and inpatient hospitalizations.4 Based on our previous
rotavirus epidemiologic study in Korea, the incidence of
rotavirus hospitalizations is likely to be 25 times more com-
mon than the incidence of IS. Such comparisons must be
confirmed by use of standardized methods in prospective
surveillance. Prospective studies in Asia will also be critical to
help understand potential explanations (e.g., diagnostic
methods) for the higher incidence rates that were observed
in earlier studies. Further work is also required to analyze the
benefits and costs of immunization for rotavirus in models
that take into account potential adverse events following
rotavirus immunization, including IS.
Acknowledgements
This study was supported by GlaxoSmithKline and research
funds of Chonbuk National University. We thank Ms Moon
Kyoung Jung for her administrative assistance.
Conflict of interest: Hans L. Bock is employed by Glax-
oSmithKline Biologicals and Timothy L. Ng was an employee
of GlaxoSmithKline Biologicals at the time of the study. Paul
E. Kilgore is a co-investigator in the RotaTeq1 Vaccine Trial in
Vietnam supported by PATH and Merck Vaccines.
References
1. Ko HS, Schenk JP, Troger J, Rohrschneider WK. Current radiolo-
gical management of intussusception in children. Eur Radiol
2007;17:2411—21.
e388 D.S. Jo et al.2. Centers for Disease Control and Prevention. Intussusception
among recipients of rotavirus vaccine–—United States, 1998—
1999. MMWR Morb Mortal Wkly Rep 1999; 48:577—81.
3. Vaccine Development Team of the Department of Vaccines and
Biologicals World Health Organization. Report of the meeting on
future directions for rotavirus vaccine research in developing
countries. Geneva: World Health Organization; 2000.
4. Kim JS, Kang JO, Cho SC, Jang YT, Min SA, Park TH, et al. Epide-
miological profile of rotavirus infection in the Republic of Korea:
results from prospective surveillance in the Jeongeub District, 1
July 2002 through 30 June 2004. J Infect Dis 2005;192(Suppl
1):S49—56.
5. Administrative Office of Planning, Jeonbuk Province. Statistics of
registered population categorized by age group and administra-
tive district. In: Jeonbuk Resident Registration Population Sta-
tistics 2001. Jeonju: Moonjungsa; 2002, p. 22—37.
6. Newcombe RG. Interval estimation for the difference between
independent proportions: comparison of eleven methods. Stat
Med 1998;17:873—90.
7. Nakagomi T, Takahashi Y, Arisawa K, Nakagomi O. A high incidence
of intussusception in Japan as studied in a sentinel hospital over a
25-year period (1978—2002). Epidemiol Infect 2006;134:57—61.
8. Justice FA, Auldist AW, Bines JE. Intussusception: trends in
clinical presentation and management. J Gastroenterol Hepatol
2006;21:842—6.
9. O’Ryan M, Lucero Y, Pena A, Valenzuela MT. Two year review of
intestinal intussusception in six large public hospitals of San-
tiago, Chile. Pediatr Infect Dis J 2003;22:717—21.
10. Perez-Schael I, Escalona M, Salinas B, Materan M, Perez ME,
Gonzalez G. Intussusception-associated hospitalization among
Venezuelan infants during 1998 through 2001: anticipating rota-
virus vaccines. Pediatr Infect Dis J 2003;22:234—9.
11. Nelson EA, Tam JS, Glass RI, Parashar UD, Fok TF. Incidence of
rotavirus diarrhea and intussusception in Hong Kong using standar-
dized hospital discharge data. Pediatr Infect Dis J 2002;21:701—3.
12. Hong Kong Intussusception Study Group. Intussusception trends
in Hong Kong children. Hong Kong Med J 2007;13:279—83.
13. Blanch AJ, Perel SB, Acworth JP. Paediatric intussusception: epi-
demiology and outcome. Emerg Med Australas 2007;19:45—50.
14. Lai AH, Phua KB, Teo EL, Jacobsen AS. Intussusception: a three-
year review. Ann Acad Med Singapore 2002;31:81—5.
15. Webby RJ, Bines JE, Barnes GL, Tindall H, Krause V, Patel M.
Intussusception in the Northern Territory: the incidence is low in
Aboriginal and Torres Strait Islander children. J Paediatr Child
Health 2006;42:235—9. discussion 27—8.16. Verschelden P, Filiatrault D, Garel L, Grignon A, Perreault G,
Boisvert J, et al. Intussusception in children: reliability of US in
diagnosis–—a prospective study. Radiology 1992;184:741—4.
17. Harrington L, Connolly B, Hu X, Wesson DE, Babyn P, Schuh S.
Ultrasonographic and clinical predictors of intussusception. J
Pediatr 1998;132:836—9.
18. Choi SO, Park WH, Woo SK. Ultrasound-guided water enema: an
alternative method of nonoperative treatment for childhood
intussusception. J Pediatr Surg 1994;29:498—500.
19. Boudville IC, Phua KB, Quak SH, Lee BW, Han HH, Verstraeten T,
et al. The epidemiology of paediatric intussusception in Singa-
pore: 1997 to 2004. Ann Acad Med Singapore 2006;35:674—9.
20. Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT,
Zimmerman CM, et al. Trends in intussusception-associated
hospitalizations and deaths among US infants. Pediatrics
2000;106:1413—21.
21. Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, de Campo M,
et al. Risk factors for intussusception in infants in Vietnam and
Australia: adenovirus implicated, but not rotavirus. J Pediatr
2006;149:452—60.
22. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the
relation between reassortant rotavirus vaccine (RotaShield)
and intussusception. J Infect Dis 2006;193:898. author reply
898—9.
23. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More
on RotaShield and intussusception: the role of age at the time of
vaccination. J Infect Dis 2005;192(Suppl 1):S36—43.
24. Tate JE, Simonsen L, Viboud C, Steiner C, PatelMM, Curns AT, et al.
Trends in intussusception hospitalizations among US infants,
1993—2004: implications for monitoring the safety of the new
rotavirus vaccination program. Pediatrics 2008;121:e1125—
e1132.
25. Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E,
et al. Postlicensure monitoring of intussusception after RotaTeq
vaccination in the United States, February 1, 2006, to September
25, 2007. Pediatrics 2008;121:1206—12.
26. Centers for Disease Control and Prevention. Rotavirus vaccina-
tion coverage and adherence to the Advisory Committee on
Immunization Practices (ACIP)-recommended vaccination sche-
dule–—United States, February 2006—May 2007. MMWR Morb
Mortal Wkly Rep 2008; 57:398—401.
27. Pruksananonda P, Athirakul K, Worawattanakul M, Varavithya W,
Pisithpun A, Kitayaporn D, et al. Intussusception in a private
tertiary-care hospital, Bangkok, Thailand: a case series. South-
east Asian J Trop Med Public Health 2007;38:339—42.
